Leon Wang
Stock Analyst at Barclays
(2.83)
# 1,745
Out of 4,868 analysts
11
Total ratings
71.43%
Success rate
18.39%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Leon Wang
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSM Insmed | Maintains: Overweight | $40 → $63 | $99.16 | -36.47% | 5 | May 29, 2024 | |
| RAPT RAPT Therapeutics | Downgrades: Equal-Weight | $13 → $4 | $7.47 | -46.42% | 3 | May 10, 2024 | |
| MLTX MoonLake Immunotherapeutics | Maintains: Equal-Weight | $41 → $59 | $43.84 | +34.58% | 3 | Sep 12, 2023 |
Insmed
May 29, 2024
Maintains: Overweight
Price Target: $40 → $63
Current: $99.16
Upside: -36.47%
RAPT Therapeutics
May 10, 2024
Downgrades: Equal-Weight
Price Target: $13 → $4
Current: $7.47
Upside: -46.42%
MoonLake Immunotherapeutics
Sep 12, 2023
Maintains: Equal-Weight
Price Target: $41 → $59
Current: $43.84
Upside: +34.58%